Compounding pharmacyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in United StatesLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under 7 spellings of its name, each linked to the record.
As of Nov 14, 2026, FDA's public records list Nephron Pharmaceuticals Corp. and its 1 subsidiaries with 18 drug recalls, 17 drug applications, 5 device recalls, 3 510(k) clearances and 1 OPDP letter. The most recent is a drug recall dated Mar 17, 2026: Albuterol Sulfate Inhalation Solution, 0.5%, 25 mg/5 mL (5 mg/mL*), 30x5 mL Sterile Unit….
Drug approvals, 510(k) clearances, recalls and letters, 2017 to 2026 to date, Nephron Pharmaceuticals Corp. and its 1 subsidiaries
A hatched bar is a year that is not over, so its count covers only part of the year.
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata. How this page is built
